Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Myeloma expression systems.

Esther M Yoo¹, Koteswara R Chintalacharuvu, Manuel L Penichet

¹Department of Microbiology, Immunology and Molecular Genetics and the Molecular Biology Institute, University of California Los Angeles, 611 S. Charles Young Drive, Los Angeles, CA 90095, USA.

Journal of Immunological Methods

|February 28, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy of an Fc-silent antibody targeting the apical domain of human transferrin receptor 1 in transgenic mouse models of Junín virus infection.

Antiviral research·2026

Same author

A Transgenic Syrian Hamster Model for New World Hemorrhagic Fever Mammarenavirus Infection.

Research square·2026

Same author

A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma.

Journal of controlled release : official journal of the Controlled Release Society·2026

Same author

Virus nanoparticle intratumoral vaccines for HER2<sup>+</sup> malignancies.

Oncoimmunology·2025

Same author

Characterization of IgE cross-reactivity and allergenicity of peanut allergens.

ImmunoHorizons·2025

Same author

Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma.

Journal of translational medicine·2025

Same journal

Optimized intracellular flow cytometry panel enables CD4 and CD8 T cell cytokine profiling in Syrian hamsters.

Journal of immunological methods·2026

Same journal

Isosulfan blue sentinel lymph node biopsy enables reliable lymph node harvest and multicolor flow cytometry in mice.

Journal of immunological methods·2026

Same journal

Type-specific antibody detection of herpes simplex virus types 1&2 (HSV-1&2) in fingerstick blood at point-of-care sites by a rapid and sensitive lateral flow immunochromatographic assay.

Journal of immunological methods·2026

Same journal

Development of chimeric DGP-IgG antibodies as quality control for celiac disease diagnosis.

Journal of immunological methods·2026

Same journal

Stepwise single-cell-resolved deep immunophenotyping pipeline to characterise immune heterogeneity and functionality in health and disease.

Journal of immunological methods·2026

Same journal

Performance evaluation of Meso Scale Discovery (MSD) quantitative serological assays for detection of binding (IgG, IgA, IgM) and ACE2 inhibitory antibody levels for SARS-CoV-2.

Journal of immunological methods·2026

See all related articles

Myeloma cell lines are effective for producing recombinant proteins, especially antibodies. These cells facilitate proper post-translational modifications, crucial for antibody function and therapeutic applications.

Area of Science:

Biotechnology
Immunology
Molecular Biology

Background:

Myeloma cell lines are professional immunoglobulin-secreting cells.
They perform essential post-translational modifications, including glycosylation, vital for antibody function.

Purpose of the Study:

To highlight the utility of myeloma expression systems for recombinant protein and antibody production.
To discuss the advantages of using myeloma cells for generating antibodies with specific diagnostic and therapeutic applications.

Main Methods:

Utilizing advances in genetic engineering and molecular biology to isolate variable regions.
Manipulating immunoglobulin genes to create chimeric or humanized antibodies.
Producing novel proteins by fusing antibodies to non-immunoglobulin sequences.

Related Experiment Videos

Main Results:

Successful production of various recombinant proteins and antibodies in myeloma systems.
Generation of antibodies with retained specificity and reduced immunogenicity in humans.
Production of engineered antibodies, including chimeric, humanized, and fused proteins.

Conclusions:

Myeloma expression systems offer a robust platform for producing functional recombinant antibodies.
Engineered antibodies produced in myeloma cells hold significant potential for diagnostics and therapeutics.
Myeloma cells enable the creation of novel antibody-based proteins for diverse applications.